Dexamethasone prevents alteration of tight junction-associated proteins and barrier function in porcine choroid plexus epithelial cells after infection with Streptococcus suis in vitro

Brain Research

Volumn 1229, Issue , 2008, Pages 1-17

  Tenenbaum, Tobias ^a,b   Matalon, David ^b   Adam, Rüdiger ^a,b   Seibt, Annette ^b   Wewer, Corinna ^b   Schwerk, Christian ^a,b   Galla, Hans Joachim ^c   Schroten, Horst ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Blood cerebrospinal fluid barrier; Glucocorticoid; Meningitis; Porcine; Tight junction

Indexed keywords

ACTIN; CLAUDIN 1; DEXAMETHASONE; MITOGEN ACTIVATED PROTEIN KINASE; OCCLUDIN; OCTOXINOL; PROTEIN ZO1; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL MENINGITIS; CHOROID PLEXUS; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; EPITHELIUM CELL; GENE ACTIVATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS SUIS; SWINE; TIGHT JUNCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CAPILLARY PERMEABILITY; CELL SURVIVAL; CELLS, CULTURED; CHOROID PLEXUS; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; MANNITOL; MEMBRANE PROTEINS; RADIATION; SIGNAL TRANSDUCTION; STREPTOCOCCACEAE; SWINE; TIME FACTORS; TRITIUM;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS SUIS; SUIDAE; SUS;

EID: 49849083653     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.06.118     Document Type: Article

References (72)

1. Abramoff M.D., Magelhaes P.J., and Ram S.J. Image processing with ImageJ. Biophotonics Int. 11 (2004) 36-42
2. Allgalier A., Goethe R., Wisselink H.J., Smith H.E., and Valentin-Weigand P. Relatedness of Streptococcus suis isolates of various serotypes and clinical backgrounds as evaluated by macrorestriction analysis and expression of potential virulence traits. J. Clin. Microbiol. 39 (2000) 445-453
3. Angelow S., Zeni P., Hohn B., and Galla H.J. Phorbol ester induced short- and long-term permeabilization of the blood-CSF barrier in vitro. Brain. Res. 1063 (2005) 168-179
4. Arends J.P., and Zanen H.C. Meningitis caused by Streptococcus suis in humans. Rev. Infect. Dis. 10 (1988) 131-137
5. Balis F.M., Lester C.M., Chrousos G.P., Heideman R.L., and Poplack D.G. Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J. Clin. Oncol. 5 (1987) 202-207
6. Basuroy S., Seth A., Elias B., Naren A.P., and Rao R. MAPK interacts with occludin and mediates EGF-induced prevention of tight junction disruption by hydrogen peroxide. Biochem. J. 393 (2006) 69-77
7. Bojarski C., Weiske J., Schoneberg T., Schroder W., Mankertz J., Schulzke J.D., Florian P., Fromm M., Tauber R., and Huber O. The specific fates of tight junction proteins in apoptotic epithelial cells. J. Cell Sci. 117 (2004) 2097-2107
8. Engelhardt B., Wolburg-Buchholz K., and Wolburg H. Involvement of the choroid plexus in central nervous system inflammation. Microsc. Res. Tech. 52 (2001) 112-129
9. Förster C., Silwedel C., Golenhofen N., Burek M., Kietz S., Mankertz J., and Drenckhahn D. Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system. J. Physiol. 565 (2005) 475-486
10. Förster C., Kahles T., Kietz S., and Drenckhahn D. Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND. J. Physiol. 580 (2007) 937-949
11. Furuse M., Hirase T., Itoh M., Nagafuchi A., Yonemura S., and Tsukita S. Occludin: a novel integral membrane protein localizing at tight junctions. J. Cell Biol. 123 (1993) 1777-1788
12. Furuse M., Itoh M., Hirase T., Nagafuchi A., Yonemura S., and Tsukita S. Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J. Cell Biol. 127 (1994) 1617-1626
13. Furuse M., Fujita K., Hiiragi T., Fujimoto K., and Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J. Cell Biol. 141 (1998) 1539-1550
14. Furuse M., and Tsukita S. Claudins in occluding junctions of humans and flies. Trends Cell Biol. 16 (2006) 181-188
15. Gath U., Hakvoort A., Wegener J., Decker S., and Galla H.J. Porcine choroid plexus cells in culture: expression of polarized phenotype, maintenance of barrier properties and apical secretion of CSF-components. Eur. J. Cell Biol. 74 (1997) 68-78
16. Gottschalk M., and Segura M. The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions. Vet. Microbiol. 76 (2000) 259-272
17. Grab D.J., Perides G., Dumler J.S., Kim K.J., Park J., Kim Y.V., Nikolskaia O., Choi K.S., Stins M.F., and Kim K.S. Borrelia burgdorferi, host-derived proteases, and the blood-brain barrier. Infect. Immun. 73 (2005) 1014-1022
18. Hall J.P., Kurdi Y., Hsu S., Cuozzo J., Liu J., Telliez J.B., Seidl K.J., Winkler A., Hu Y., Green N., Askew G.R., Tam S., Clark J.D., and Lin L.L. Pharmacologic inhibition of TPL2 blocks inflammatory responses in primary human monocytes, synoviocytes, and blood. J. Biol. Chem. 282 (2007) 33295-33304
19. Harkness K.A., Adamson P., Sussman J.D., Davies-Jones G.A., Greenwood J., and Woodroofe M.N. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain 123 (2002) 698-709
20. Haselbach M., Wegener J., Decker S., Engelbertz C., and Galla H.J. Porcine choroid plexus epithelial cells in culture: regulation of barrier properties and transport processes. Microsc. Res. Tech. 52 (2001) 137-152
21. Hofman P. Pathological interactions of bacteria and toxins with the gastrointestinal epithelial tight junctions and/or the zonula adherens: an update. Cell. Mol. Biol. (Noisy-le-grand) 49 (2003) 65-75
22. Högger P. What happens in the body with glucocorticoids? Pharmacokinetics and pharmacodynamics. Pharm.Unserer Zeit. 32 (2003) 296-301
23. Hoheisel D., Nitz T., Franke H., Wegener J., Hakvoort A., Tilling T., and Galla H.J. Hydrocortisone reinforces the blood-brain barrier properties in a serum free cell culture system. Biochem. Biophys. Res. Commun. 244 (1998) 312-316
24. Howe K.L., Reardon C., Wang A., Nazli A., and McKay D.M. Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability. Am. J. Pathol. 167 (2005) 1587-1597
25. Ikenouchi J., Furuse M., Furuse K., Sasaki H., Tsukita S., and Tsukita S. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J. Cell. Biol. 171 (2005) 939-945
26. Itoh M., Furuse M., Morita K., Kubota K., Saitou M., and Tsukita S. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J. Cell Biol. 147 (1999) 1351-1363
27. Itoh M., Morita K., and Tsukita S. Characterization of ZO-2 as a MAGUK family member associated with tight as well as adherens junctions with a binding affinity to occludin and alpha catenin. J. Biol. Chem. 274 (1999) 5981-5986
28. Jobin M.C., and Grenier D. Identification and characterization of four proteases produced by Streptococcus suis. FEMS Microbiol. Lett. 220 (2003) 113-119
29. Jobin M.C., Fortin J., Willson P.J., Gottschalk M., and Grenier D. Acquisition of plasmin activity and induction of arachidonic acid release by Streptococcus suis in contact with human brain microvascular endothelial cells. FEMS Microbiol. Lett. 252 (2005) 105-111
30. Kim K.S. Pathogenesis of bacterial meningitis, from bacteraemia to neuronal injury. Nat. Rev. Neurosci. 4 (2003) 376-385
31. Leib S.L., Kim Y.S., Chow L.L., Sheldon R.A., and Tauber M.G. Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci. J. Clin. Investig. 98 (1996) 2632-2639
32. Lohmann C., Krischke M., Wegener J., and Galla H.J. Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways. Brain Res. 995 (2004) 184-196
33. Lu Y., Fukuda K., Liu Y., Kumagai N., and Nishida T. Dexamethasone inhibition of IL-1-induced collagen degradation by corneal fibroblasts in three-dimensional culture. Invest. Ophthalmol. Vis. Sci. 45 (2004) 2998-3004
34. Lutsar I., Friedland I.R., Jafri H.S., Wubbel L., Ahmed A., Trujillo M., McCoig C.C., and McCracken Jr. G.H. Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis. J. Antimicrob. Chemother. 52 (2003) 651-655
35. Madsen L.W., Svensmark B., Elvestad K., Aalbaek B., and Jensen H.E. Streptococcus suis serotype 2 infection in pigs: new diagnostic and pathogenetic aspects. J. Comp. Pathol. 126 (2002) 57-65
36. Matter K., and Balda M.S. Signalling to and from tight junctions. Nat. Rev. Mol. Cell. Biol. 4 (2003) 225-236
37. Matter K., and Balda M.S. Epithelial tight junctions, gene expression and nucleo-junctional interplay. J. Cell Sci. 120 (2007) 1505-1511
38. Muza-Moons M.M., Schneeberger E.E., and Hecht G.A. Enteropathogenic Escherichia coli infection leads to appearance of aberrant tight junctions strands in the lateral membrane of intestinal epithelial cells. Cell Microbiol. 6 (2004) 783-793
39. Nusrat A., von Eichel-Streiber C., Turner J.R., Verkade P., Madara J.L., and Parkos C.A. Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect. Immun. 69 (2001) 1329-1336
40. Raman M., Chen W., Cobb M.H., Raman M., Chen W., and Cobb M.H. Differential regulation and properties of MAPKs. Oncogene 26 (2007) 3100-3112
41. Romero I.A., Radewicz K., Jubin E., Michel C.C., Greenwood J., Couraud P.O., and Adamson P. Changes in cytoskeletal and tight junctional proteins correlate with decreased permeability induced by dexamethasone in cultured rat brain endothelial cells. Neurosci. Lett. 344 (2003) 112-116
42. Rosenberg G.A. Matrix metalloproteinases in neuroinflammation. Glia. 39 (2002) 279-291
43. Rothstein R.P., and Lewinson S.P. Damage to the choroid plexus, ependyma and subependyma as a consequence of perinatal hypoxia/ischemia. Dev. Neurosci. 24 (2002) 426-436
44. Saitou M., Fujimoto K., Doi Y., Itoh M., Fujimoto T., and Furuse M. Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J. Cell Biol. 141 (1998) 397-408
45. Saitou M., Furuse M., Sasaki H., Schulzke J.D., Fromm M., Takano H., Noda T., and Tsukita S. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol. Biol. Cell. 11 (2000) 4131-4142
46. Sakaguchi T., Kohler H., Gu X., McCormick B.A., and Reinecker H.C. Shigella flexneri regulates tight junction-associated proteins in human intestinal epithelial cells. Cell Microbiol. 4 (2002) 367-381
47. Sakakibara A., Furuse M., Saitou M., Ando-Akatsuka Y., and Tsukita S. Possible involvement of phosphorylation of occludin in tight junction formation. J. Cell Biol. 137 (1997) 1393-1401
48. Sanford S. Gross and histopathological findings in unusual lesions caused by Streptococcus suis in pigs. II. Central nervous system lesions. Can. J. Vet. Res. 51 (1987) 486-489
49. Scheld W.M., Koedel U., Nathan B., and Pfister H.W. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J. Infect. Dis. 186 (2002) S225-S233
50. Simonovic I., Rosenberg J., Koutsouris A., and Hecht G. Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions. Cell Microbiol. 2 (2000) 305-315
51. Slevogt H., Schmeck B., Jonatat C., Zahlten J., Beermann W., van Laak V., Opitz B., Dietel S., N'Guessan P.D., Hippenstiel S., Suttorp N., and Seybold J. Moraxella catarrhalis induces inflammatory response of bronchial epithelial cells via MAPK and NF-kappaB activation and histone deacetylase activity reduction. Am. J. Physiol. Lung. Cell Mol. Physiol. 290 (2006) L818-L826
52. Sonoda N., Furuse M., Sasaki H., Yonemura S., Katahira J., Horiguchi Y., and Tsukita S. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands. Evidence for direct involvement of claudins in tight junction barrier. J. Cell Biol. 147 (1999) 195-204
53. Staats J.J., Feder I., Okwumabua O., and Chengappa M.M. Streptococcus suis, past and present. Vet. Res. Commun. 21 (1997) 381-407
54. Strazielle N., and Ghersi-Egea J.F. Choroid plexus in the central nervous system: biology and physiopathology. J. Neuropathol. Exp. Neurol. 59 (2000) 561-574
55. Strazielle N., Khuth S.T., Murat A., Chalon A., Giraudon P., Belin M.F., and Ghersi-Egea J.F. Pro-inflammatory cytokines modulate matrix metalloproteinase secretion and organic anion transport at the blood-cerebrospinal fluid barrier. J. Neuropathol. Exp. Neurol. 62 (2003) 1254-1264
56. Strupp M. Inflammatory CNS disorders: use of dexamethasone in bacterial meningitis and new insights in multiple sclerosis. J. Neurol. 255 (2008) 149-151
57. Tenenbaum T., Adam R., Eggenpöhler I., Matalon D., Seibt A., Novotny G., Galla H.J., and Schroten H. Disruption of the blood-CSF barrier by Streptococcus suis in vitro. FEMS Immunol. Med. Microbiol. 44 (2005) 25-34
58. Tenenbaum T., Essmann F., Adam R., Seibt A., Janicke R.U., Novotny G.E., Galla H.J., and Schroten H. Cell death, caspase activation, and HMGB1 release of porcine choroid plexus epithelial cells during Streptococcus suis infection in vitro. Brain Res. 1100 (2006) 1-12
59. Tuomanen E. Can microbial pathogenesis team up with immunology?. Trends Microbiol. 3 (1995) 456-457
60. Tsukita S., Furuse M., and Itoh M. Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol. 2 (2001) 285-293
61. van der Flier M., Geelen S.P., Kimpen J.L., Hoepelman I.M., and Tuomanen E.I. Reprogramming the host response in bacterial meningitis: how best to improve outcome?. Clin. Microbiol. Rev. 16 (2003) 415-429
62. van Furth A.M., Roord J.J., and van Furth R. Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect. Immun. 64 (1996) 4883-4890
63. Wang Y., Zhang J., Yi X.J., and Yu F.S. Activation of ERK1/2 MAP kinase pathway induces tight junction disruption in human corneal epithelial cells. Exp. Eye. Res. 78 (2004) 125-136
64. Weidenfeller C., Schrot S., Zozulya A., and Galla H.J. Murine brain capillary endothelial cells exhibit improved barrier properties under the influence of hydrocortisone. Brain Res. 1053 (2005) 162-174
65. Westermarck J., and Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13 (1999) 781-792
66. Williams A.E., and Blakemore W.F. Pathogenesis of meningitis caused by Streptococcus suis type 2. J. Infect. Dis. 162 (1990) 474-481
67. Witek-Zawada B., and Koj A. Regulation of expression of stromyelysin-1 by proinflammatory cytokines in mouse brain astrocytes. J. Physiol. Pharmacol. 54 (2003) 489-496
68. Wittchen E.S., Haskins J., and Stevenson B.R. Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J. Biol. Chem. 274 (1999) 35179-35185
69. Wong V. Phosphorylation of occludin correlates with occludin localization and function at the tight junction. Am. J. Physiol. 273 (1997) C1859-C1867
70. Yan C., and Boyd D.D. Regulation of matrix metalloproteinase gene expression. J. Cell Physiol. 211 (2007) 19-26
71. Zeni P., Doepker E., Schulze Topphoff U., Huewel S., Tenenbaum T., and Galla H.J. MMPs contribute to TNF-alpha induced alteration of the blood-cerebrospinal fluid barrier in vitro. Am. J. Physiol. Cell Physiol. 293 (2007) C855-C864
72. Zettl K.S., Sjaastad M.D., Riskin P.M., Parry G., Machen T.E., and Firestone G.L. Glucocorticoid-induced formation of tight junctions in mouse mammary epithelial cells in vitro. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 9069-9073